AB0904 BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Denton, C. P. ; Spiera, R. ; Jörg, D. ; Khanna, D. ; Kreuter, M. ; Kuwana, M. ; Volkmann, E. ; Cotic, J. ; Raji, O. ; Hammer, A. ; Zeccin, C. ; Van Maurik, A. ; Olaiz, J. M. ; Fahy, W. ; Tomlinson, R. ; Dastros-Pitei, D. ; Nihtyanova, S. ; Irving, E. ; Maher, T.

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1668-1668 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível